HealthCor Catalio Acquisition Corp.

Status: Live Deal
U=S
Target: Hyperfine and Liminal Sciences
IPO Proceeds, $M $207.00M
IPO Date Jan 27, 2021
CEO Art Cohen
Left Lead Jefferies
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Healthcare, including the biotechnology, pharmaceuticals, services, and medical technology sub-sectors

IPO Geography Global
Target Company Hyperfine and Liminal Sciences
Deal Announced Jul 8, 2021
Deal Size, $M $581.30M
Deal Geography US/Canada
Deal Sector Healthcare
SEC Filings www.sec.gov
HCAQ


Sign up for Free Trial

No credit card required

Sign in for more data on HealthCor Catalio Acquisition Corp.:

  • 9 directors & officers
  • 9 filings and events
  • 1 underwriters
  • 7 deal advisors
  • 3 legal advisors
  • 80 shareholders (from 13F filings)